AIDS-Related Kaposi Sarcoma, Version 2.2019

Autor: Evie Carchman, Julian Sanchez, Gita Suneja, Kevin L. Ard, Michelle A. Rudek, Mary A. Dwyer, Oxana V. Crysler, Neel K. Gupta, Allison Hall, David S. Morgan, Chelsea Gustafson, Manoj P. Menon, Lee Ratner, Benjamin Tomlinson, Jeff Taylor, Ann H. Klopp, Nitya Nathwani, Adam L. Cohen, Sai Yendamuri, Stacey A. Rizza, Deborah A. Freedman-Cass, Kimberly L. Johung, Richard F. Ambinder, Ann S. LaCasce, Chia Ching J. Wang, Robert A. Baiocchi, Ariela Noy, Erin Reid, Stefan K. Barta, Chi Lin, Amitkumar Mehta
Rok vydání: 2019
Předmět:
Zdroj: Journal of the National Comprehensive Cancer Network. 17:171-189
ISSN: 1540-1413
1540-1405
DOI: 10.6004/jnccn.2019.0008
Popis: As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.
Databáze: OpenAIRE